Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRC | Q99895 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 3/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19242233 | 0.77 | ELANE (0.36) | CTRCELANEGABRA1GABRB2TLR8 | |
| SCHEMBL28174447 | 0.76 | ALDH1A1 (0.34) | CTRCTDP1PARP1 | |
| SCHEMBL5745630 | 0.73 | CTRC (0.39) | CTRCGABRA1GABRB2SMN1; SMN2 | |
| SCHEMBL21899425 | 0.72 | P2RX7 (0.31) | — | |
| SCHEMBL9181886 | 0.71 | CTRC (0.38) | CTRCSMN1; SMN2 | |
| SCHEMBL18910424 | 0.70 | CTRC (0.36) | CTRC | |
| SCHEMBL2036773 | 0.70 | GABRP (0.43) | CTRCTDP1GABRA1GABRB2SMN1; SMN2 | |
| SCHEMBL28827733 | 0.69 | KMT2A (0.53) | GABRA1GABRB2PARP1 | |
| SCHEMBL12658946 | 0.69 | CTRC (0.48) | CTRCGABRA1GABRB2 | |
| SCHEMBL13495961 | 0.69 | SLC40A1 (0.38) | CTRCTDP1GABRA1GABRB2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107074896-B | Electroluminescent imidazoquinoxaline carbene metal complexes | UDC 爱尔兰有限责任公司 | 2021-04-13 | — | — | CN | disclosed |
| US-10784448-B2 | Electroluminescent imidazo-quinoxaline carbene metal complexes | UDC IRELAND LIMITED (IE) | 2020-09-22 | — | — | US | disclosed |
| US-10784448-B2 | Electroluminescent imidazo-quinoxaline carbene metal complexes | UDC IRELAND LIMITED (IE) | 2020-09-22 | — | — | US | disclosed |
| EP-3466957-A1 | OLED COMPRISING AN ELECTROLUMINESCENT IMIDAZO-QUINOXALINE CARBENE METAL COMPLEXES | UDC Ireland Limited (IE) | 2019-04-10 | — | — | EP | disclosed |
| EP-3466957-A1 | OLED COMPRISING AN ELECTROLUMINESCENT IMIDAZO-QUINOXALINE CARBENE METAL COMPLEXES | UDC Ireland Limited (IE) | 2019-04-10 | — | — | EP | disclosed |
| EP-3186264-B1 | ELECTROLUMINESCENT IMIDAZO-QUINOXALINE CARBENE METAL COMPLEXES | UDC IRELAND LTD (IE) | 2018-11-28 | — | — | EP | disclosed |
| US-20170237020-A1 | Electroluminescent Imidazo-Quinoxaline Carbene Metal Complexes | BASF SE (DE) | 2017-08-17 | — | — | US | disclosed |
| US-20170237020-A1 | Electroluminescent Imidazo-Quinoxaline Carbene Metal Complexes | BASF SE (DE) | 2017-08-17 | — | — | US | disclosed |
| US-20170237020-A1 | Electroluminescent Imidazo-Quinoxaline Carbene Metal Complexes | BASF SE (DE) | 2017-08-17 | — | — | US | disclosed |
| EP-3186264-A1 | ELECTROLUMINESCENT IMIDAZO-QUINOXALINE CARBENE METAL COMPLEXES | UDC Ireland Limited (IE) | 2017-07-05 | — | — | EP | disclosed |
| WO-2016020516-A1 | ELECTROLUMINESCENT IMIDAZO-QUINOXALINE CARBENE METAL COMPLEXES | BASF SE (DE) | 2016-02-11 | — | — | WO | disclosed |
| WO-2016020516-A1 | ELECTROLUMINESCENT IMIDAZO-QUINOXALINE CARBENE METAL COMPLEXES | BASF SE (DE) | 2016-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10784448-B2 | Electroluminescent imidazo-quinoxaline carbene metal complexes | OCIAD1, OCIAD2, OXER1 | CTRC 2837/4885TDP1 4129/4885ELANE 2639/4885 |
| US-20170237020-A1 | Electroluminescent Imidazo-Quinoxaline Carbene Metal Complexes | OCIAD1, OCIAD2, OXER1 | CTRC 2837/4885TDP1 4129/4885ELANE 2639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.